Pharmacokinetics and Lymphatic Delivery of Oligopeptide after Intramuscular Injection of Oligopeptide-bearing Liposomes to Rats |
Shin, Dae-Hwan
(National Research Laboratory of PK/PD, CBITRC, College of Pharmacy, Chungbuk National University)
Cho, Byung-Suk (National Research Laboratory of PK/PD, CBITRC, College of Pharmacy, Chungbuk National University) Choi, Kyu-Seok (National Research Laboratory of PK/PD, CBITRC, College of Pharmacy, Chungbuk National University) Song, Suk-Gil (National Research Laboratory of PK/PD, CBITRC, College of Pharmacy, Chungbuk National University) Lee, Chong-Kil (National Research Laboratory of PK/PD, CBITRC, College of Pharmacy, Chungbuk National University) Chung, Youn-Bok (National Research Laboratory of PK/PD, CBITRC, College of Pharmacy, Chungbuk National University) |
1 | T. Arichi, T. Saito, M.E. Major, I.M. Belyakov, M. Shirai and V.H. Engelhard, Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model, Proc. Natl. Acad. Sci. USA., 97, 297-302 (2000) |
2 | R. Schirmbeck, X. Zheng, M. Roggendorf, M. Geissler, F.V. Chisari and J. Reimann, Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen, J. Immunol., 166, 1405-1413 (2001) DOI |
3 | M. Hohne, S. Schaefer, M. Seifer, M.A. Feitelson, D. Paul and W.H. Gerlich, Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA, EMBO. J., 9, 1137-1145 (1990) |
4 | N. Yasunari, L.G. Guiditti, C.V. Kohien, P. Fowler and F.V. Chisari, Immune pathogenesis of hepatocellular carcinoma, J. Exp. Med., 188, 341-350 (1998) DOI |
5 | A. Tamori, S. Nishiguchi, S. Kubo, N. Koh, Y. Moriyama and S. Fujimoto, Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus, Hepatology., 29, 1429-1434 (1999) DOI ScienceOn |
6 | M.J. Garlepp, W. Chen, H. Tabarias, M. Baines, A. Brooks and J. McCluskey, Antigen processing and presentation by a murine myoblast cell line, Clin. Exp. Immunol., 102, 614- 619 (1995) DOI |
7 | E. Lara-Pezzi, P.L. Majano, M. Gomez-Gonzalo, C. Garcia- Monzon, R. Moreno-Otero, and M. Levrero, The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes, Hepatology., 28, 1013-1021 (1998) DOI ScienceOn |
8 | R. Nayersina, P. Fowler, S. Guilhot, G. Missale, A. Cerny, H.J. Schlicht, A. Vitiello, R. Chesnut, J.L. Person and A.G. Redeker, HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol., 150, 4659- 4671 (1993) |
9 | A. Antonio and H.K. Ulrich, Viral mechanism of immune evasion. Mol. Med. Today, 6, 365-372 (2000) DOI ScienceOn |
10 | N. Murray and A. McMichael, Antigen presentation in virus infection, Curr. Opin. Immunol., 4, 401-407 (1992) DOI ScienceOn |
11 | H. Hanaue, T. Kurosawa, Y. Kitano, S. Miyakawa, F. Horie, A. Nemoto and J. Shikata, N1-(2-Tetrahydrofuryl)-5-fluorouracil (FT-207) in the postoperative adjuvant chemotherapy of gastric cancer, Cancer, 57, 693-698 (1986) DOI ScienceOn |
12 | I. Mellman and R.M. Steinman, Dendritic cells specialized and regulated antigen processing machines, Cell., 106, 255- 258 (2001) DOI ScienceOn |
13 | P.E. Harris, A.I. Colovai, A. Maffei, Z. Liu and N.S. Foca, Major histocompatibility complex class I presentation of exogenous and endogenous protein-derived peptides by a transfected human monocyte cell line, Immunology, 86, 606- 611 (1995) |
14 | K. Hirano and C.A. Hunt, Lymphatic transport of liposomeencapsulated agents; effects of liposome size following intraperitoneal administration, J. Pharm. Sci., 74, 915-921 (1985) DOI |
15 | J. Sugihara, S. Furuuchi, K. Nakano and S. Harigaya, Studies on intestinal lymphatic absorption of drugs I. Lymphatic absorption of alkyl ester derivatives and amomoglyceride derivatives of drugs, J. Pharmacobio-Dyn., 11, 369-344 (1988) DOI |
16 | F.V. Chisari and C. Ferrari, Hepatitis B virus immunopathogenesis, Annu. Rev. Immunol., 13, 29-60 (1995) DOI ScienceOn |
17 | D. Loirat, F.A. Lemonnier and M.L. Michel, Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization, J. Immunol., 165, 4748-4755 (2000) DOI |
18 | Q. Su, C.H. Schroder, W.J. Hofmann, G. Otto, R. Pichlmayr and P. Bannasch, Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas, Hepatology., 27, 1109-1120 (1998) DOI ScienceOn |
19 | J.S. Chang, M.J. Choi, T.Y. Kim, G.J. Woo, S. Chung and H.S. Cheong, Effect of dehydration and rehydration of the pH-sensitive liposomes containing chimeric gag-V3 virus like particle on their long-term stability, Biotechnol. Bioprocess. Eng., 4, 66-71 (1999) DOI ScienceOn |
20 | U. Protzer and H. Schaller, Immune escape by Hepatitis B virus, Virus Genes., 21, 27-37 (2000) DOI ScienceOn |
21 | M. Takeuchi, J. Fujimoto, H. Niwamoto, Y. Yamamoto and E. Okamoto, Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients, Dig. Dis. Sci., 42, 2264-2269 (1997) DOI ScienceOn |
22 | S. Kobayashi, K. Saigoh, T. Urashima, T. Asano and K. Isono, Detection of hepatitis B virus x transcripts in human hepatocellular carcinoma tissues, J. Surg. Res., 73, 97-100 (1997) DOI ScienceOn |